Skin Virome Profiling Market Size, Share, Scope, Forecast Report 2026 to 2035

What is Skin Virome Profiling Market Size?

Skin Virome Profiling Market Size is valued at USD 382.49 Mn in 2025 and is predicted to reach USD 1,291.21 Mn by the year 2035 at a 13.2% CAGR during the forecast period for 2026 to 2035.

Skin Virome Profiling Market Size, Share & Trends Analysis by Technology (Next-Generation Sequencing, PCR-Based Methods, Microarray, Others), by Application (Clinical Diagnostics, Research, Personalized Medicine, Others), by End-User (Hospitals & Clinics, Research Institutes, Diagnostic Laboratories, Others), by Sample Type (Swab, Biopsy, Others), and Segment Forecasts, 2026 to 2035

Skin virome profiling is the process of characterizing and analyzing viruses living in human skin by applying next-generation sequencing (NGS), metagenomics, PCR, and bioinformatics methods. These viruses include bacteriophages, eukaryotic viruses, and others that contribute greatly to the skin health, immune system, and disease development processes. By profiling these communities, scientists and clinicians may get a better insight on how the skin microbiome interacts with various diseases such as eczema, psoriasis, acne, atopic dermatitis, chronic wounds, and skin infections.

One of the major drivers behind the expansion of the skin virome profiling market is the increasing interest in the studies of microbiomes. While most of them are still centered around bacteria and their microbiomes, many researchers begin to consider the contribution of viruses into the health of skin tissues and its diseases. Moreover, technological innovations in sequencing and computational biology make the analysis faster, accurate, and affordable. At the same time, investments into precision medicine and personalized dermatology inspire medical professionals to use the information about the microbiome in patient care.

Additionally, pharmaceutical and biotech firms are now employing skin virome profiling in their drug discovery and biomarker identification processes. The cosmetics industry too is embracing virome profiling as they try to come up with microbiome-friendly cosmetic products that ensure good skin health without disturbing its microbial balance. Increased knowledge of microbiome therapy, increased clinical activity, and investment in microbiome research are some of the factors that will contribute to future market growth.

Competitive Landscape

Which are the Leading Players in Skin Virome Profiling Market?

• Illumina Inc.
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies plc
• Pacific Biosciences (PacBio)
• CosmosID
• BaseClear B.V.
• Microba Life Sciences
• Zymo Research Corporation
• CD Genomics
• Charles River Laboratories
• Eurofins Scientific
• Novogene Co., Ltd.
• F. Hoffmann-La Roche Ltd.
• bioMérieux SA
• Seegene Inc.
• BGI Genomics
• CosmosID
• Second Genome
• Diversigen (OraSure Technologies)
• Viome Life Sciences
• DNA Genotek
• Integrated DNA Technologies (IDT)
• GENEWIZ (Azenta Life Sciences)
• Metagenopolis
• Eagle Genomics
• uBiome Technologies (Historical)
• Biotia
• CoreBiome
• Resphera Biosciences

Market Dynamics

Driver

Rising Adoption of Microbiome-Based Precision Medicine

Rising adoption of precision medicine is anticipated to propel the skin virome profiling market growth over the forecast period. The shift towards individualized therapy based on patient-specific biology is being pursued by healthcare professionals. Skin virome profiling enables detection of virus-host interactions affecting immune response and disease progression enabling doctors to take an effective course of action. It is especially useful in treating chronic skin diseases like psoriasis, eczema, and atopic dermatitis due to the involvement of the skin microbiome in these conditions. With the development of next-generation sequencing technology, there has been significant progress in reducing the cost of sequencing while improving accuracy and speed of data processing. Coupled with artificial intelligence and bioinformatics platforms, this makes it easier to understand complex viral communities. With the continued interest of the pharmaceutical industry in the microbiome therapeutics and biomarker discovery, demand for virome profiling is likely to grow over the forecast period.

Restrain/Challenge

High Cost of Sequencing and Lack of Standardized Analytical Methods

Although there have been great advances in technology, the skin virome profiling market still encounters a number of difficulties. The main problem that hinders the development of the skin virome market is the high price of new sequencing technology and bioinformatic analysis. The full profiling of the virome requires complex equipment, qualified personnel and technical capabilities, which raises costs significantly for many healthcare facilities and research laboratories. Moreover, the lack of standardized procedures for the collection of samples, their sequencing, analysis of the obtained results and the presentation of the research results leads to the inconsistency between various studies. Also, the lack of information about the biological role of the skin virome and lack of clinical trials are limiting factors in the adoption of this technique. 

Dermatological Disease Diagnosis Segment is Expected to Drive the Skin Virome Profiling Market

The dermatological disease diagnosis market was led by the dermatological disease diagnosis segment, which held the highest share in 2025. Increasing prevalence of chronic inflammatory skin conditions, growing awareness about microbiome diagnostics, and adoption of molecular diagnostic techniques have contributed to segment growth. With skin virome profiling, doctors are able to detect viral markers that cause progression of the disease and help diagnose the condition with proper treatment plan.

Metagenomic Sequencing Segment is Growing at the Highest Rate in the Skin Virome Profiling Market

The metagenomics sequencing category held the largest share in the market in 2025 owing to its capability to identify both known and novel viruses in an extensive manner, irrespective of prior target selection. This is because the technique facilitates the identification of biomarkers along with enabling microbiome studies and also ensures high-resolution characterization of microbial viruses.

Why North America Led the Skin Virome Profiling Market?

North America was the dominant player of the global skin virome profiling market in 2025. The region features an efficient biotech ecosystem, large investments in microbiome research, state-of-the-art infrastructure for genomic sequencing, and high healthcare spending. Availability of major sequencing technology players, pharmaceutical players, and academic research institutes has facilitated innovation in the field of microbiome profiling. The US remains a dominant country for microbiome research through large-scale government funding, collaboration between research institutes and biotechnology organizations, and growing adoption of genomic techniques in clinical settings. Growing awareness about personalized medicine along with research related to microbial therapy are some of the drivers contributing to regional market growth.

Key Development

• In May 2025, Oxford Nanopore Technologies announced technology updates at London Calling 2025, highlighting advances in real-time sequencing, distributed sequencing, high-output workflows, and multiomics discovery, which support broader use of long-read sequencing in metagenomics and virome research.

Skin Virome Profiling Market Report Scope: